Wolverine Trading, LLC Exact Sciences Corp Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

27 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $780,712 - $1.3 Million	18,400 Added 50.97%	54,500 $3.71 Million
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $1.11 Million - $2 Million	-26,900 Reduced 42.7%	36,100 $1.53 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $950,963 - $1.25 Million	16,900 Added 36.66%	63,000 $4.35 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $2.72 Million - $3.49 Million	46,100 New	46,100 $3.41 Million
Q2 2023 Aug 23, 2023	BUY	$62.68 - $95.05 $2.78 Million - $4.22 Million	44,400 Added 125.78%	79,700 $7.48 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $1.02 Million - $1.54 Million	-21,700 Reduced 38.07%	35,300 $2.34 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $221,555 - $387,995	7,300 Added 14.69%	57,000 $2.82 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $1.59 Million - $2.45 Million	49,700 New	49,700 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $1.47 Million - $3.16 Million	-41,400 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $2.76 Million - $3.96 Million	-48,000 Reduced 53.69%	41,400 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $1.2 Million - $1.66 Million	16,500 Added 22.63%	89,400 $6.96 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $1.99 Million - $2.74 Million	22,100 Added 43.5%	72,900 $6.68 Million
Q2 2021 Aug 06, 2021	SELL	$93.66 - $139.27 $1.29 Million - $1.92 Million	-13,800 Reduced 21.36%	50,800 $6.51 Million
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $1.15 Million - $1.53 Million	-9,900 Reduced 13.29%	64,600 $7.99 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $677,348 - $966,416	6,800 Added 10.04%	74,500 $10.1 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $627,112 - $877,286	8,600 Added 14.55%	67,700 $6.91 Million
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $239,725 - $398,825	4,300 Added 7.85%	59,100 $5.08 Million
Q1 2020 May 11, 2020	SELL	$37.9 - $104.44 $1.57 Million - $4.32 Million	-41,400 Reduced 43.04%	54,800 $3.2 Million
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $1.41 Million - $1.81 Million	18,100 Added 23.18%	96,200 $8.84 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $1.05 Million - $1.42 Million	11,600 Added 17.44%	78,100 $7.19 Million
Q2 2019 Aug 20, 2019	BUY	$89.51 - $118.04 $1.65 Million - $2.17 Million	18,400 Added 38.25%	66,500 $7.85 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $1.54 Million - $2.39 Million	-24,800 Reduced 34.02%	48,100 $4.17 Million
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $930,264 - $1.37 Million	16,600 Added 29.48%	72,900 $4.46 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $550,506 - $918,839	11,400 Added 25.39%	56,300 $4.44 Million
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $1.08 Million - $1.56 Million	-27,100 Reduced 37.64%	44,900 $1.81 Million
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $790,330 - $1.03 Million	17,000 Added 30.91%	72,000 $3.78 Million
Q3 2017 Nov 15, 2017	BUY	$37.05 - $47.12 $2.04 Million - $2.59 Million	55,000	55,000 $2.59 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$997 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$889 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$804 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$677 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$375 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account